To date, KIM-1 is seemingly the most multifaceted and nuanced RCC biomarker identified, with cheaper and more facile clinical applicability than previously described genetic markers, but similarly lacking external validation. The gene discussed is HAVCR1; the disease is renal cell carcinoma.